The New York Times is reporting top White House officials are blocking new Food and Drug Administration guidelines that would likely delay the approval of any coronavirus vaccine until after November 3. The FDA wants to monitor the health of trial volunteers for two months to make sure there are no long-term side effects, but the White House opposes the plan.

In other medical news, the CDC has acknowledged COVID-19 can be spread by airborne transmission in indoor settings. The CDC had made a similar statement in September but then removed the information from its website.